NOS2 and neoplasm: TLR activation upregulates pro-tumourigenic pathways, including the induction of inducible nitric oxide synthase (iNOS2) and cyclooxygenase (COX) 2, to promote a feed-forward loop leading to tumour progression and the development of more aggressive tumour phenotypes [9].